Additional evidence suggests that angiogenic factors such as VEGF, PGE2, and IL-10 promote the surface expression of Fas ligand (FasL) on the tumor endothelium, creating an immunosuppressive microenvironment by selective of CD8+ T-cells [74]. This evidence concerns the gene FASLG and neoplasm.